pSK41-like plasmid is necessary for inc18-like vanA plasmid transfer from enterococcus faecalis to staphylococcus aureus in vitro

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 1, 2013, Pages 212-219

  Zhu, Wenming ^a   Clark, Nancye ^a   Patel, Jean B ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BACTERIAL PROTEIN; PLASMID DNA; UNCLASSIFIED DRUG; VANA PROTEIN;

ARTICLE; BACTERIUM CONJUGATION; BACTERIUM ISOLATE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; HUMAN; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PLASMID; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; UNITED STATES; VANCOMYCIN RESISTANT STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CARBON-OXYGEN LIGASES; CONJUGATION, GENETIC; ENTEROCOCCUS FAECALIS; HUMANS; METHICILLIN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; PLASMIDS; SEQUENCE ANALYSIS, DNA; STAPHYLOCOCCUS AUREUS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 84872035499     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01587-12     Document Type: Article

References (41)

1. Zhu W, Clark NC, McDougal LK, Hageman J, McDonald LC, Patel JB. 2008. Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan. Antimicrob. Agents Chemother. 52:452-457.
2. Zhu W, Murray PR, Huskins WC, Jernigan JA, McDonald LC, Clark NC, Anderson KF, McDougal LK, Hageman JC, Olsen-Rasmussen M, Frace M, Alangaden GJ, Chenoweth C, Zervos MJ, Robinson-Dunn B, Schreckenberger PC, Reller LB, Rudrik JT, Patel JB. 2010. Dissemination of an Enterococcus Inc18-like vanA plasmid associated with vancomycin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 54: 4314-4320.
3. Banerjee T, Anupurba S. 2012. Colonization with vancomycin-intermediate Staphylococcus aureus strains containing the vanA resistance gene in a tertiary-care center in north India. J. Clin. Microbiol. 50:1730-1732.
4. Tiwari HK, Sen MR. 2006. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India. BMC Infect. Dis. 6:156. doi:10.1186/1471-2334-6-156.
5. Aligholi M, Emaneini M, Jabalameli F, Shahsavan S, Dabiri H, Sedaght H. 2008. Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini Hospital in Tehran. Med. Principles Pract. 17:432-434.
6. Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC. 2008. Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin. Infect. Dis. 46:668-674.
7. Gould IM. 2010. VRSA-doomsday superbug or damp squib? Lancet Infect. Dis. 10:816-818.
8. Weigel LM, Clewell DB, Gill SR, Clark NC, McDougal LK, Flannagan SE, Kolonay JF, Shetty J, Killgore GE, Tenover FC. 2003. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 302:1569-1571.
9. Weigel LM, Donlan RM, Shin DH, Jensen B, Clark NC, McDougal LK, Zhu W, Musser KA, Thompson J, Kohlerschmidt D, Dumas N, Limberger RJ, Patel JB. 2007. High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm. Antimicrob. Agents Chemother. 51:231-238.
10. Grohmann E, Muth G, Espinosa M. 2003. Conjugative plasmid transfer in gram-positive bacteria. Microbiol. Mol. Biol. Rev. 67:277-301.
11. Thompson JK, Collins MA. 1988. Evidence for the conjugal transfer of the broad host range plasmid pIP501 into strains of Lactobacillus helveticus. J. Appl. Bacteriol. 65:309-319.
12. Langella P, Chopin A. 1989. Conjugal transfer of plasmid pIP501 from Lactococcus lactis to Lactobacillus delbrueckii subsp. bulgaricus and Lactobacillus helveticus. FEMS Microbiol. Lett. 51:149-152.
13. Schaberg DR, Clewell DB, Glatzer L. 1982. Conjugative transfer of R-plasmids from Streptococcus faecalis to Staphylococcus aureus. Antimicrob. Agents Chemother. 22:204-207.
14. Gonzalez CF, Kunka BS. 1983. Plasmid transfer in Pediococcus spp.: intergeneric and intrageneric transfer of pIP501. Appl. Environ. Microbiol. 46:81-89.
15. Shearer JE, Wireman J, Hostetler J, Forberger H, Borman J, Gill J, Sanchez S, Mankin A, Lamarre J, Lindsay JA, Bayles K, Nicholson A, O'Brien F, Jensen SO, Firth N, Skurray RA, Summers AO. 2011. Major families of multiresistant plasmids from geographically and epidemiologically diverse staphylococci. G3 1:581-591.
16. Berg T, Firth N, Apisiridej S, Hettiaratchi A, Leelaporn A, Skurray RA. 1998. Complete nucleotide sequence of pSK41: evolution of staphylococcal conjugative multiresistance plasmids. J. Bacteriol. 180:4350-4359.
17. Clewell DB, Francia MV. 2004. Conjugation in gram-positive bacteria, p 227-256. In Funnell BE, Phillips GJ (ed), Plasmid biology. ASM Press, Washington, DC.
18. Archer GL, Dietrick DR, Johnston JL. 1985. Molecular epidemiology of transmissible gentamicin resistance among coagulase-negative staphylococci in a cardiac surgery unit. J. Infect. Dis. 151:243-251.
19. Archer GL, Johnston JL. 1983. Self-transmissible plasmids in staphylococci that encode resistance to aminoglycosides. Antimicrob. Agents Chemother. 24:70-77.
20. Jaffe HW, Sweeney HM, Nathan C, Weinstein RA, Kabins SA, Cohen S. 1980. Identity and interspecific transfer of gentamicin-resistance plasmids in Staphylococcus aureus and Staphylococcus epidermidis. J. Infect. Dis. 141: 738-747.
21. Apisiridej S, Leelaporn A, Scaramuzzi CD, Skurray RA, Firth N. 1997. Molecular analysis of a mobilizable theta-mode trimethoprim resistance plasmid from coagulase-negative staphylococci. Plasmid 38:13-24.
22. Projan SJ, Archer GL. 1989. Mobilization of the relaxable Staphylococcus aureus plasmid pC221 by the conjugative plasmid pGO1 involves three pC221 loci. J. Bacteriol. 171:1841-1845.
23. Thomas WD, Jr, Archer GL. 1992. Mobilization of recombinant plasmids from Staphylococcus aureus into coagulase negative Staphylococcus species. Plasmid 27:164-168.
24. Zechner EL, Lang S, Schildbach JF. 2012. Assembly and mechanisms of bacterial type IV secretion machines. Philos. Trans. R. Soc. London Ser. B Biol. Sci. 367:1073-1087.
25. Novick R. 1967. Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus. Virology 33:155-166.
26. Kreiswirth BN, Lofdahl S, Betley MJ, O'Reilly M, Schlievert PM, Bergdoll MS, Novick RP. 1983. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 305:709-712.
27. Firth N, Apisiridej S, Berg T, O'Rourke BA, Curnock S, Dyke KG, Skurray RA. 2000. Replication of staphylococcal multiresistance plasmids. J. Bacteriol. 182:2170-2178.
28. Evers S, Sahm DF, Courvalin P. 1993. The vanB gene of vancomycin-resistant Enterococcus faecalis V583 is structurally related to genes encoding D-Ala:D-Ala ligases and glycopeptide-resistance proteins vanA and vanC. Gene 124:143-144.
29. Nicholson A, Schoonover MDV, McDougal L, Limbago B. 2005. Identification and molecular characterization of pSK41-bearing methicillin-resistant Staphylococcus aureus (MRSA) from ongoing, large-scale surveillance of invasive disease, United States-06. SHEA/IDSA 2010, Atlanta, GA.
30. Zhu W, Clark N, Patel JB. 2008. Conjugal transfer of vancomycin resistance from Enterococcus faecalis to Staphylococcus aureus, abstr. C2-269. 48th Intersci. Conf. Antimicrob. Agents Chemother.
31. Flannagan SE, Clewell DB. 2002. Identification and characterization of genes encoding sex pheromone cAM373 activity in Enterococcus faecalis and Staphylococcus aureus. Mol. Microbiol. 44:803-817.
32. Waldron DE, Lindsay JA. 2006. SauI: a novel lineage-specific type I restriction-modification system that blocks horizontal gene transfer into Staphylococcus aureus and between S. aureus isolates of different lineages. J. Bacteriol. 188:5578-5585.
33. Clinical and Laboratory Standards Institute. 2010. Methods of antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline, 2nd ed. M45-A2. CLSI, Wayne, PA.
34. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing. CLSI, Wayne, PA.
35. Dutka-Malen S, Evers S, Courvalin P. 1995. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J. Clin. Microbiol. 33:1434.
36. Sung JM, Lindsay JA. 2007. Staphylococcus aureus strains that are hypersusceptible to resistance gene transfer from enterococci. Antimicrob. Agents Chemother. 51:2189-2191.
37. Barrangou R, Horvath P. 2009. The CRISPR system protects microbes against phages, plasmids: palindromic DNA repeat sequences immunize microorganisms against phages and plasmids, while also directing their evolution. Microbe 4:224-230.
38. Marraffini LA, Sontheimer EJ. 2008. CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science 322:1843-1845.
39. Firth N, Fink PD, Johnson L, Skurray RA. 1994. A lipoprotein signal peptide encoded by the staphylococcal conjugative plasmid pSK41 exhibits an activity resembling that of Enterococcus faecalis pheromone cAD1. J. Bacteriol. 176:5871-5873.
40. Lazazzera BA. 2001. The intracellular function of extracellular signaling peptides. Peptides 22:1519-1527.
41. Abajy MY, Kopec J, Schiwon K, Burzynski M, Doring M, Bohn C, Grohmann E. 2007. A type IV-secretion-like system is required for conjugative DNA transport of broad-host-range plasmid pIP501 in grampositive bacteria. J. Bacteriol. 189:2487-2496.